Results 201 to 210 of about 16,645 (269)

The Use of Direct Oral Anticoagulants (DOACs) in the Geriatric Population-How to Overcome the Challenges of Geriatric Syndromes. [PDF]

J Clin Med
Badescu MC, Popescu D, Gosav EM, Costache AD, Cosău DE, Chetran A, Duca ȘT, Cucută S, Șerban IL, Costache Enache II, Rezus C.   +10 more
europepmc   +1 more source

Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment [PDF]

, 2016

core   +1 more source

Chronic coronary syndrome and new-onset atrial fibrillation or venous thromboembolism: how best to manage antithrombotic therapy strategies. [PDF]

Eur Heart J Cardiovasc Pharmacother
Rubboli A, Angiolillo DJ, Becattini C, Lip GYH.   +3 more
europepmc   +1 more source

Editorial Comment: Non-Vitamin K Antagonist Oral Anticoagulants for Thromboembolic Prevention in Patients with Atrial Fibrillation and Concomitant Mitral Stenosis: A Retrospective Observational Study. [PDF]

Acta Cardiol Sin
Liu CM, Chao TF.
europepmc   +1 more source

Real-world evidence comparing oral anticoagulants for NVAF in Europe: a systematic review and network meta-analysis. [PDF]

Future Cardiol
Cichewicz A, Jawla S, Zuchinali P, Akin-Fajiye M, Massierer D, Porto I, Garcia-Moll X.   +6 more
europepmc   +1 more source

Recurrent Cancer-Associated Nonbacterial Endocarditis Presenting With Systemic Embolic Complications. [PDF]

JACC Case Rep
Nakamura K, Yamashita Y, Koyama S, Sunada M, Tanji M, Horie T, Ono K.   +6 more
europepmc   +1 more source

Challenges in Performing Real-World Evidence Studies in Low-Middle Income Countries: the EdoBRA Study. [PDF]

Arq Bras Cardiol
Massaro AR.
europepmc   +1 more source

Andexanet Alfa in Urgent Cardiac Surgery: A Case Report of Edoxaban Reversal for Acute Hemopericardium. [PDF]

Am J Case Rep
Al Mawed M, Warkentin H, Brockmeier JP, Schramm R, Gummert J, von Dossow V, Gielen S.   +6 more
europepmc   +1 more source

Recurrent Dural Arteriovenous Fistula following Cerebral Venous Sinus Thrombosis Related to COVID-19 Vaccination: A Case Report. [PDF]

NMC Case Rep J
Iwabuchi N, Yoshida M, Kumai M, Nishijima Y, Niizuma K, Endo H.   +5 more
europepmc   +1 more source

Nordic mcl2-3 trials: mirna-18b overexpression identifies a mantle cell lymphoma subgroup with poor survival and improves mipi-b prediction of prognosis [PDF]

, 2014
Brown, P. D. N., Clasen-Linde, E., Delabie, J., Ehinger, M., Ek, Sara, Garde, Christian, Geisler, C. H., Gronbaek, K., Husby, Sofie, Jerkeman, M., Karjalainen-Lindsberg, M. L., Kolstad, A., Laurell, A., Ralfkiaer, U., Raty, R., Sundstrom, C., Workman, Christopher   +16 more
core